Ticker Scorecard - BCRX Basics Company: BioCryst Pharmaceuticals, Inc. IPO Date: March 4, 1994 Sector: Healthcare Industry: Biotech Market Cap: $1.59B Activated in VL: True Average Daily Range Avg Daily Range: $0.21 | 3.08% Avg Daily Range (30 D): $0.17 | 2.25% Avg Daily Range (90 D): $0.17 | 2.24% Institutional Daily Volume Avg Daily Volume: 1.47M Avg Daily Volume (30 D): 1.41M Avg Daily Volume (90 D): 1.55M Trade Size Avg Trade Size (Sh.): 183 Avg Trade Size (Sh.) (30 D): 93 Avg Trade Size (Sh.) (90 D): 100 Institutional Trades Total Inst.Trades: 3,448 Avg Inst. Trade: $2.2M Avg Inst. Trade (30 D): $2.24M Avg Inst. Trade (90 D): $2.19M Avg Inst. Trade Volume: .27M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.08M Avg Closing Trade (30 D): $2.51M Avg Closing Trade (90 D): $2.44M Avg Closing Volume: 376.1K     News Jan 7, 2025 @ 12:00 PM BioCryst to Present at 43rd Annual J.P. Morgan Hea... Source: N/A Nov 6, 2024 @ 12:00 PM BioCryst to Present at Upcoming Investor Conferenc... Source: N/A Nov 5, 2024 @ 12:00 PM BioCryst Reports Inducement Grants Under Nasdaq Li... Source: N/A Sep 30, 2024 @ 11:00 AM U.S. Government Awards BioCryst $69 Million RAPIVA... Source: Biocryst Pharmaceuticals, Inc. Sep 17, 2024 @ 11:00 AM BioCryst and the pan-Canadian Pharmaceutical Allia... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.61 $-.07 $-.06 Diluted EPS $-.61 $-.07 $-.06 Revenue $ 412.58M $ 117.09M $ 109.33M Gross Profit $ 404.85M $ 113.87M $ 107.63M Net Income / Loss $ -123.82M $ -14.03M $ -12.67M Operating Income / Loss $ -40.71M $ 7.69M $ 8.76M Cost of Revenue $ 7.73M $ 3.21M $ 1.7M Net Cash Flow $ -53.43M $ 18.86M $ -5.93M PE Ratio